Breaking News, Collaborations & Alliances

ProBioGen, Boehringer Partner on DirectedLuck Transposase Technology

Achieves high protein expression and maximum stability, reducing time and manual lab work for selecting superior clones for best titers and product quality.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ProBioGen entered a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen’s DirectedLuck transposase technology. Financial terms of the agreement were not disclosed.   ProBioGen and Boehringer Ingelheim have collaborated going back to 2011, when the company was one of the early adopters of ProBioGen’s afucosylation technology GlymaxX.    The new project further expands the partner’s long-term collaboration on new technologies for R&D. It contributes to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters